Healthcare -
Biotechnology - NASDAQ - US
$ 13.49
-0.369 %
$ 195 M
Market Cap
0.11
P/E
INBX - CASH FROM OPERATIONS
Cash from Operations INBX - Inhibrx Biosciences, Inc.
-193 M
LAST VALUE
-55.13%
2 YEAR CAGR
-52.95%
5 YEAR CAGR
0.00%
10 YEAR CAGR